Study: Actonel Reduces Vertebral Fracture Risk 70% In Patients On Steroids.
Publication: Immunotherapy Weekly
Publication Date: 14-NOV-01
How to access the full article: Free access to all articles is available courtesy of your local library. To access the full article click the "See the full article" button below. You will need your US library barcode or password.
2001 NOV 14 - (NewsRx.com & NewsRx.net) -- Vertebral fracture risk in men and women who take oral glucocorticoid treatment (>7.5 mg/day prednisone or equivalent) for chronic diseases is significantly reduced with Actonel (risedronate sodium tablets) 5 mg in just one year, according to data presented at the 66th Annual Scientific Meeting of the American College of Gastroenterology in Las Vegas.
Patients on Actonel 5 mg daily while initiating or continuing glucocorticoid (a class of steroids) therapy experienced significant vertebral...
Read the full article for free courtesy of your local library.
Bookmark this article
Print this article
Link to this article
Email this article
Digg It!
Add to del.icio.us
RSS
